World Clinical Drug
|
2025, 46(8): 863-868
Comparative analysis of the "Dual-Channel" management policies for national medical insurance negotiated drugs
Full
Weiping LI, Rongfan SHEN, Jiamin WU, Zixuan DONG, Chenda ZHANG, Meimei HE*
Affiliations
- School of Management, Beijing University of Chinese Medicine, Beijing 100029, China
Published: 2025-08-10
doi: 10.13683/j.wph.2025.08.020
Outline
"dual-channel" management
/
national negotiated medicines
/
selection of designated medical and pharmaceutical institutions
/
medical insurance reimbursement
李玮萍, 沈荣蕃, 武佳敏, 董子暄, 张辰达, 何敏媚.
国家医保谈判药品“双通道”管理政策比较分析.
世界临床药物,
2025
, 46
(8)
: 863
-868
.
DOI: 10.13683/j.wph.2025.08.020
Weiping LI, Rongfan SHEN, Jiamin WU, Zixuan DONG, Chenda ZHANG, Meimei HE.
Comparative analysis of the "Dual-Channel" management policies for national medical insurance negotiated drugs[J].
World Clinical Drug,
2025
, 46
(8)
: 863
-868
.
DOI: 10.13683/j.wph.2025.08.020
Year 2025 volume 46 Issue 8
47
9
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.08.020
- Receive Date:2024-12-19
- Online Date:2026-11-09
- Published:2025-08-10